These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Bridged bicyclic 2,3-dioxabicyclo[3.3.1]nonanes as antiplasmodial agents: Synthesis, structure-activity relationships and studies on their biomimetic reaction with Fe(II). D'Alessandro S; Alfano G; Di Cerbo L; Brogi S; Chemi G; Relitti N; Brindisi M; Lamponi S; Novellino E; Campiani G; Gemma S; Basilico N; Taramelli D; Baratto MC; Pogni R; Butini S Bioorg Chem; 2019 Aug; 89():103020. PubMed ID: 31185392 [TBL] [Abstract][Full Text] [Related]
23. Synthesis and notable antimalarial activity of acyclic peroxides, L-(alkyldioxy)-L-(methyldioxy)cyclododecanes. Hamada Y; Tokuhara H; Masuyama A; Nojima M; Kim HS; Ono K; Ogura N; Wataya Y J Med Chem; 2002 Mar; 45(6):1374-8. PubMed ID: 11882006 [TBL] [Abstract][Full Text] [Related]
24. Endoperoxide antimalarials: development, structural diversity and pharmacodynamic aspects with reference to 1,2,4-trioxane-based structural scaffold. Rudrapal M; Chetia D Drug Des Devel Ther; 2016; 10():3575-3590. PubMed ID: 27843298 [TBL] [Abstract][Full Text] [Related]
25. Novel endoperoxide antimalarials: synthesis, heme binding, and antimalarial activity. Taylor DK; Avery TD; Greatrex BW; Tiekink ER; Macreadie IG; Macreadie PI; Humphries AD; Kalkanidis M; Fox EN; Klonis N; Tilley L J Med Chem; 2004 Mar; 47(7):1833-9. PubMed ID: 15027875 [TBL] [Abstract][Full Text] [Related]
26. Preparation of Antimalarial Endoperoxides by a Formal [2 + 2 + 2] Cycloaddition. Daeppen C; Kaiser M; Neuburger M; Gademann K Org Lett; 2015 Nov; 17(21):5420-3. PubMed ID: 26491785 [TBL] [Abstract][Full Text] [Related]
27. New 4-aminobicyclo[2.2.2]octane derivatives and their activities against Plasmodium falciparum and Trypanosoma b. rhodesiense. Seebacher W; Brun R; Weis R Eur J Pharm Sci; 2004 Feb; 21(2-3):225-33. PubMed ID: 14757494 [TBL] [Abstract][Full Text] [Related]
28. Antimalarial and cytotoxic activities of bicycl. Fujishima H; Takeshita H; Toyota M; Kim HS; Wataya Y; Tanaka M; Sasaki T; Ihara M Chem Pharm Bull (Tokyo); 2001 May; 49(5):572-5. PubMed ID: 11383608 [TBL] [Abstract][Full Text] [Related]
30. Orally active antimalarial 3-substituted trioxanes: new synthetic methodology and biological evaluation. Posner GH; Cumming JN; Woo SH; Ploypradith P; Xie S; Shapiro TA J Med Chem; 1998 Mar; 41(6):940-51. PubMed ID: 9526568 [TBL] [Abstract][Full Text] [Related]
31. Antimalarial activity of new water-soluble dihydroartemisinin derivatives. 3. Aromatic amine analogues. Lin AJ; Li LQ; Klayman DL; George CF; Flippen-Anderson JL J Med Chem; 1990 Sep; 33(9):2610-4. PubMed ID: 2202831 [TBL] [Abstract][Full Text] [Related]
32. Comparison of the reactivity of antimalarial 1,2,4,5-tetraoxanes with 1,2,4-trioxolanes in the presence of ferrous iron salts, heme, and ferrous iron salts/phosphatidylcholine. Bousejra-El Garah F; Wong MH; Amewu RK; Muangnoicharoen S; Maggs JL; Stigliani JL; Park BK; Chadwick J; Ward SA; O'Neill PM J Med Chem; 2011 Oct; 54(19):6443-55. PubMed ID: 21888440 [TBL] [Abstract][Full Text] [Related]
33. Synthesis and antimalarial efficacy of aza-fused rhodacyanines in vitro and in the P. berghei mouse model. Takasu K; Pudhom K; Kaiser M; Brun R; Ihara M J Med Chem; 2006 Jul; 49(15):4795-8. PubMed ID: 16854088 [TBL] [Abstract][Full Text] [Related]
35. Discovery of a bulky 2-tert-butyl group containing primaquine analogue that exhibits potent blood-schizontocidal antimalarial activities and complete elimination of methemoglobin toxicity. Jain M; Vangapandu S; Sachdeva S; Singh S; Singh PP; Jena GB; Tikoo K; Ramarao P; Kaul CL; Jain R J Med Chem; 2004 Jan; 47(2):285-7. PubMed ID: 14711300 [TBL] [Abstract][Full Text] [Related]
36. Alkylation of natural endoperoxide G3-factor. Synthesis and antimalarial activity studies. Najjar F; Gorrichon L; Baltas M; André-Barrès C; Vial H Org Biomol Chem; 2005 May; 3(9):1612-4. PubMed ID: 15858637 [TBL] [Abstract][Full Text] [Related]
37. Synthesis of bicyclic amines and their activities against Trypanosoma brucei rhodesiense and Plasmodium falciparum K1. Weis R; Berger H; Kaiser M; Brun R; Saf R; Seebacher W Arch Pharm Res; 2008 Jun; 31(6):688-97. PubMed ID: 18563349 [TBL] [Abstract][Full Text] [Related]
38. Antimalarial activity of 6-(1,2,6,7-tetraoxaspiro[7.11]nonadec-4-yl)hexan-1-ol (N-251) and its carboxylic acid derivatives. Sato A; Kawai S; Hiramoto A; Morita M; Tanigawa N; Nakase Y; Komichi Y; Matsumoto M; Hiraoka O; Hiramoto K; Tokuhara H; Masuyama A; Nojima M; Higaki K; Hayatsu H; Wataya Y; Kim HS Parasitol Int; 2011 Dec; 60(4):488-92. PubMed ID: 21924377 [TBL] [Abstract][Full Text] [Related]
39. Antimalarial and antiplasmodial activities of norneolignans. Syntheses and SAR. Skytte DM; Nielsen SF; Chen M; Zhai L; Olsen CE; Christensen SB J Med Chem; 2006 Jan; 49(1):436-40. PubMed ID: 16392829 [TBL] [Abstract][Full Text] [Related]
40. Synthesis and antimalarial activity in vitro and in vivo of a new ferrocene-chloroquine analogue. Biot C; Glorian G; Maciejewski LA; Brocard JS J Med Chem; 1997 Nov; 40(23):3715-8. PubMed ID: 9371235 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]